(STL.News) British drugmaker AstraZeneca said its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of Covid-19, based on early data from a trial.

YouTube video provided courtesy of The Straights Times

By STLNEWS

STL.News is owned and operated by STL.News, LLC. We publish States Top Leading News. Our news is timely, unbiased and content is obtained direct from the source to obtain reliable information. Additionally, we will publish YouTube news video from major media companies.